167 related articles for article (PubMed ID: 10777708)
21. Acute and long-term effects of nateglinide on insulin secretory pathways.
Ball AJ; Flatt PR; McClenaghan NH
Br J Pharmacol; 2004 May; 142(2):367-73. PubMed ID: 15155541
[TBL] [Abstract][Full Text] [Related]
22. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
[TBL] [Abstract][Full Text] [Related]
23. Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K+ channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors.
Schwanstecher C; Dickel C; Panten U
Mol Pharmacol; 1992 Mar; 41(3):480-6. PubMed ID: 1545776
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
25. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat.
Berdeu D; Gross R; Puech R; Loubatières-Mariani MM; Bertrand G
Eur J Pharmacol; 1995 Feb; 275(1):91-8. PubMed ID: 7774667
[TBL] [Abstract][Full Text] [Related]
26. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
[TBL] [Abstract][Full Text] [Related]
27. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
[TBL] [Abstract][Full Text] [Related]
28. Plasma membrane depolarization as a determinant of the first phase of insulin secretion.
Hatlapatka K; Willenborg M; Rustenbeck I
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E315-22. PubMed ID: 19470830
[TBL] [Abstract][Full Text] [Related]
29. BTS 67 582 stimulates insulin secretion from perifused rat pancreatic islets.
Dickinson K; North TJ; Sills S; Anthony DM; Lock JI; Vowles DT; Jones RB
Eur J Pharmacol; 1997 Nov; 339(1):69-76. PubMed ID: 9450618
[TBL] [Abstract][Full Text] [Related]
30. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
31. Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
de Heer J; Holst JJ
Diabetes; 2007 Feb; 56(2):438-43. PubMed ID: 17259389
[TBL] [Abstract][Full Text] [Related]
32. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.
Hohmeier HE; Mulder H; Chen G; Henkel-Rieger R; Prentki M; Newgard CB
Diabetes; 2000 Mar; 49(3):424-30. PubMed ID: 10868964
[TBL] [Abstract][Full Text] [Related]
33. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.
Ashcroft FM; Gribble FM
J Diabetes Complications; 2000; 14(4):192-6. PubMed ID: 11004427
[TBL] [Abstract][Full Text] [Related]
34. Alterations of insulin secretion following long-term manipulation of ATP-sensitive potassium channels by diazoxide and nateglinide.
Ball AJ; Flatt PR; McClenaghan NH
Biochem Pharmacol; 2005 Jan; 69(1):59-63. PubMed ID: 15588714
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.
Szollosi A; Nenquin M; Henquin JC
Br J Pharmacol; 2010 Feb; 159(3):669-77. PubMed ID: 20128805
[TBL] [Abstract][Full Text] [Related]
36. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
Bleck C; Wienbergen A; Rustenbeck I
Diabetes; 2004 Dec; 53 Suppl 3():S135-9. PubMed ID: 15561901
[TBL] [Abstract][Full Text] [Related]
37. Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.
McClenaghan NH; Flatt PR; Ball AJ
J Endocrinol; 2006 Sep; 190(3):889-96. PubMed ID: 17003289
[TBL] [Abstract][Full Text] [Related]
38. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
39. The effects of trypsin on ATP-sensitive potassium channel properties and sulfonylurea receptors in the CRI-G1 insulin-secreting cell line.
Lee K; Ozanne SE; Rowe IC; Hales CN; Ashford ML
Mol Pharmacol; 1994 Jul; 46(1):176-85. PubMed ID: 8058051
[TBL] [Abstract][Full Text] [Related]
40. Tambulin from Zanthoxylum armatum acutely potentiates the glucose-induced insulin secretion via K
Hameed A; Raza SA; Israr Khan M; Baral J; Adhikari A; Nur-E-Alam M; Ahmed S; Al-Rehaily AJ; Ashraf S; Ul-Haq Z; Hafizur RM
Biomed Pharmacother; 2019 Dec; 120():109348. PubMed ID: 31629954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
